NL302572A - - Google Patents

Info

Publication number
NL302572A
NL302572A NL302572DA NL302572A NL 302572 A NL302572 A NL 302572A NL 302572D A NL302572D A NL 302572DA NL 302572 A NL302572 A NL 302572A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL302572A publication Critical patent/NL302572A/xx

Links

NL302572D 1962-12-27 NL302572A (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP6427663 1963-10-29
JP5741963 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
NL302572A true NL302572A (pl)

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
NL302572D NL302572A (pl) 1962-12-27

Country Status (5)

Country Link
BE (1) BE641880A (pl)
FR (1) FR3150M (pl)
GB (1) GB1080599A (pl)
LU (1) LU45106A1 (pl)
NL (1) NL302572A (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
SI2319581T1 (sl) 2004-11-26 2015-10-30 Ucl Business Plc Pripravki, ki obsegajo ornitin in fenilacetat ali fenilbutirat za zdravljenje hepatične encefalopatije
BRPI1013657A2 (pt) 2009-04-03 2016-04-26 Ocera Therapeutics Inc composições, processos de produção ade sal de acetato de fenil l-ornitina, método de compressão de acetato de fenil l-ornitina e uso de quantidade terapeuticamente efetiva de forma cristalina do sal de acetato de fenil l-ornitina
KR20170026672A (ko) 2009-06-08 2017-03-08 유씨엘 비즈니스 피엘씨 L―오르니틴 페닐아세테이트를 사용한 문맥압 항진증의 치료 및 간 기능 회복
KR101888215B1 (ko) 2010-10-06 2018-09-20 오세라 테라퓨틱스, 아이엔씨. L-오르니틴 페닐아세테이트의 제조 방법
CN107206021B (zh) 2014-11-24 2021-09-03 Ucl商业有限公司 使用降氨疗法治疗与肝星状细胞激活相关的疾病
US10835506B2 (en) 2015-08-18 2020-11-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
IL270413B (en) 2017-05-11 2022-08-01 Ocera Therapeutics Inc Processes for the preparation of l-ornithine phenylacetate
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Also Published As

Publication number Publication date
BE641880A (pl) 1964-04-16
LU45106A1 (pl) 1964-02-24
GB1080599A (en) 1967-08-23
FR3150M (fr) 1965-02-22

Similar Documents

Publication Publication Date Title
BE630640A (pl)
BE616548R (pl)
BE614739A (pl)
BE489310A (pl)
AU269855A (pl)
LU45106A1 (pl)
BE633369A (pl)
BE632172A (pl)
BE631769A (pl)
BE631669A (pl)
BE631269A (pl)
AU480751A (pl)
BE380301A (pl)
BE630619A (pl)
BE630333A (pl)
BE614566A (pl)
BE629944A (pl)
BE629880A (pl)
BE629872A (pl)
BE629378A (pl)
BE628946A (pl)
BE628701A (pl)
BE627733A (pl)
BE627394A (pl)
BE627343A (pl)